TdT activity, 5′- and 3′-exonuclease activities, and insertion of P nucleotides in IGKV-J and IGLV-J rearrangements in the present series
. | κ-CLL . | . | λ-CLL . | . | ||
|---|---|---|---|---|---|---|
. | Positivity, no. (%) . | Median (range) . | Positivity, no. (%) . | Median (range) . | ||
| TdT | 91 (51.5) | 3 (1-12) | 46 (47.7) | 3 (1-15) | ||
| P nucleotides | 18 (10.3) | 2 (1-3) | 4 (4.5) | 2 (2-3) | ||
| 5′-exonuclease | 132 (75.2) | 3 (1-16) | 66 (68.2) | 2 (1-10) | ||
| 3′-exonuclease | 116 (66.1) | 2 (1-8) | 71 (72.7) | 3 (1-7) | ||
. | κ-CLL . | . | λ-CLL . | . | ||
|---|---|---|---|---|---|---|
. | Positivity, no. (%) . | Median (range) . | Positivity, no. (%) . | Median (range) . | ||
| TdT | 91 (51.5) | 3 (1-12) | 46 (47.7) | 3 (1-15) | ||
| P nucleotides | 18 (10.3) | 2 (1-3) | 4 (4.5) | 2 (2-3) | ||
| 5′-exonuclease | 132 (75.2) | 3 (1-16) | 66 (68.2) | 2 (1-10) | ||
| 3′-exonuclease | 116 (66.1) | 2 (1-8) | 71 (72.7) | 3 (1-7) | ||